161 related articles for article (PubMed ID: 213959)
1. VIP: the cause of the watery diarrhoea syndrome.
Modlin IM; Bloom SR; Mitchell S
Adv Exp Med Biol; 1978; 106():195-201. PubMed ID: 213959
[No Abstract] [Full Text] [Related]
2. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
3. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
Said SI
World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
[TBL] [Abstract][Full Text] [Related]
4. WDHA syndrome caused by VIP-producing ganglioneuroblastoma.
Kudo K; Kitajima S; Munakata H; Yagihashi S
J Pediatr Surg; 1982 Aug; 17(4):426-8. PubMed ID: 6288909
[TBL] [Abstract][Full Text] [Related]
5. Watery diarrhea syndrome. Two unusual cases and further evidence that VIP is a humoral mediator.
Cooperman AM; Desantis D; Winkelman E; Farmer R; Eversman J; Said S
Ann Surg; 1978 Mar; 187(3):325-8. PubMed ID: 205179
[TBL] [Abstract][Full Text] [Related]
6. VIPomas and the watery diarrhoea syndrome.
Modlin IM; Bloom SR
S Afr Med J; 1978 Jul; 54(2):53-6. PubMed ID: 705537
[TBL] [Abstract][Full Text] [Related]
7. [An autopsy case of WDHA syndrome].
Sakaguchi A; Tajiri T; Shima Y; Nishi S; Nishioka S; Yataka I; Gen E
Nihon Shokakibyo Gakkai Zasshi; 1982 Oct; 79(10):1991-4. PubMed ID: 6296499
[No Abstract] [Full Text] [Related]
8. Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.
Tiedemann K; Pritchard J; Long R; Bloom SR
Eur J Pediatr; 1981 Oct; 137(2):217-9. PubMed ID: 6118274
[TBL] [Abstract][Full Text] [Related]
9. Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide.
Long RG; Bryant MG; Yuille PM; Polak JM; Bloom SR
Gut; 1981 Jun; 22(6):505-11. PubMed ID: 7021331
[TBL] [Abstract][Full Text] [Related]
10. [A syndrome of watery diarrhea, hypokalemia and hypochlorhydria caused by vasoactive-intestinal-polypeptide producing tumor (author's transl)].
Kawanaka M; Ohiwa N; Toyooka K; Matsuoka T; Mori T; Kakishita E; Nagai K; Yamaguchi K; Abe K; Kameya T
Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1546-54. PubMed ID: 744898
[No Abstract] [Full Text] [Related]
11. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
Devine BL; Carmichael HA; Russell RI; Joffe SN
Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
[TBL] [Abstract][Full Text] [Related]
12. Evidence for secretion of vasoactive intestinal peptide by tumours of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept.
Said SI
Clin Endocrinol (Oxf); 1976; 5 Suppl():201S-204S. PubMed ID: 29733
[TBL] [Abstract][Full Text] [Related]
13. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
14. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
[TBL] [Abstract][Full Text] [Related]
15. Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome.
Modlin IM; Bloom SR; Mitchell SJ
Gastroenterology; 1978 Dec; 75(6):1051-4. PubMed ID: 710857
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment.
Bloom SR
Am J Dig Dis; 1978 Apr; 23(4):373-6. PubMed ID: 208414
[No Abstract] [Full Text] [Related]
17. Plasma VIP in patients with watery diarrhea syndrome.
Gardner JD
Am J Dig Dis; 1978 Apr; 23(4):370-3. PubMed ID: 665633
[No Abstract] [Full Text] [Related]
18. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
Bloom SR; Polak JM
Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal hormones in clinical disease: recent developments.
Ann Intern Med; 1979 May; 90(5):817-28. PubMed ID: 219742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
